The RSI Indicator for MIST moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 28 of the 30 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 57 cases where MIST's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for MIST just turned positive on October 12, 2026. Looking at past instances where MIST's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.
Following a +3.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where MIST advanced for three days, in 220 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
MIST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MIST as a result. In 73 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for MIST entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.435) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (44.843) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. MIST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The 10-day moving average for RCKT crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for RCKT turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 41 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
RCKT moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCKT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for RCKT entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for RCKT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCKT advanced for three days, in 205 of 256 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
RCKT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.777) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. RCKT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCKT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
MIST | RCKT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 58 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 44 Fair valued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 92 | |
PRICE GROWTH RATING 1..100 | 87 | 88 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 39 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RCKT's Valuation (11) in the Biotechnology industry is somewhat better than the same rating for MIST (44) in the Pharmaceuticals Major industry. This means that RCKT’s stock grew somewhat faster than MIST’s over the last 12 months.
RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MIST (100) in the Pharmaceuticals Major industry. This means that RCKT’s stock grew similarly to MIST’s over the last 12 months.
RCKT's SMR Rating (92) in the Biotechnology industry is in the same range as MIST (100) in the Pharmaceuticals Major industry. This means that RCKT’s stock grew similarly to MIST’s over the last 12 months.
MIST's Price Growth Rating (87) in the Pharmaceuticals Major industry is in the same range as RCKT (88) in the Biotechnology industry. This means that MIST’s stock grew similarly to RCKT’s over the last 12 months.
MIST's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as RCKT (100) in the Biotechnology industry. This means that MIST’s stock grew similarly to RCKT’s over the last 12 months.
| MIST | RCKT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| Stochastic ODDS (%) | 1 day ago 86% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 88% | N/A |
| MACD ODDS (%) | 1 day ago 84% | 6 days ago 84% |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 85% |
| Advances ODDS (%) | 3 days ago 84% | 10 days ago 80% |
| Declines ODDS (%) | 10 days ago 84% | 4 days ago 87% |
| BollingerBands ODDS (%) | 5 days ago 83% | 1 day ago 80% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 82% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MIST’s FA Score shows that 0 FA rating(s) are green while RCKT’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MIST’s TA Score shows that 5 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).
MIST (@Biotechnology) experienced а -7.54% price change this week, while RCKT (@Biotechnology) price change was -14.84% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -18.33%, and the average quarterly price growth was -21.56%.
MIST is expected to report earnings on Nov 17, 2026.
RCKT is expected to report earnings on Nov 05, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BNO | 67.19 | 2.33 | +3.59% |
| United States Brent Oil Fund LP (BNO) | |||
| TYLD | 25.35 | 0.01 | +0.06% |
| Cambria Tactical Yield ETF (TYLD) | |||
| FENI | 39.71 | -0.06 | -0.15% |
| Fidelity Enhanced International ETF (FENI) | |||
| HIDV | 88.90 | -0.75 | -0.84% |
| AB US High Dividend ETF (HIDV) | |||
| HODU | 10.04 | -1.16 | -10.34% |
| Direxion Daily HOOD Bull 2X ETF (HODU) | |||
A.I.dvisor indicates that over the last year, MIST has been loosely correlated with TSHA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MIST jumps, then TSHA could also see price increases.
| Ticker / NAME | Correlation To MIST | 1D Price Change % | ||
|---|---|---|---|---|
| MIST | 100% | -10.98% | ||
| TSHA - MIST | 40% Loosely correlated | -2.95% | ||
| RCUS - MIST | 40% Loosely correlated | -3.07% | ||
| ABEO - MIST | 38% Loosely correlated | -4.73% | ||
| RCKT - MIST | 38% Loosely correlated | -7.63% | ||
| ARVN - MIST | 38% Loosely correlated | -2.65% | ||
More | ||||
A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with VYGR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then VYGR could also see price increases.
| Ticker / NAME | Correlation To RCKT | 1D Price Change % | ||
|---|---|---|---|---|
| RCKT | 100% | -7.63% | ||
| VYGR - RCKT | 55% Loosely correlated | -7.77% | ||
| PRME - RCKT | 55% Loosely correlated | -3.88% | ||
| STOK - RCKT | 55% Loosely correlated | -1.79% | ||
| FDMT - RCKT | 54% Loosely correlated | -5.67% | ||
| SLDB - RCKT | 54% Loosely correlated | -3.66% | ||
More | ||||